YOLFTbeta
Cardiol Therapeutics Inc Class A

Cardiol Therapeutics Inc Class A

CRDL · NASDAQ · Healthcare / Drug Manufacturers - Specialty & Generic

1.00USD-0.04 (-3.85%)

Price History

Full chart

Market Stats

Previous Close1.04
Open1.02
Day Range0.9702 – 1.04
52-Week Range0.88 – 2.34
Volume451.14K
Market Cap210.22M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.24
Dividend Yield0.00%
Beta0.61
50-Day Avg1.68
200-Day Avg1.26

About

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. David G. Elsley MBA
  • Employees18
  • Headquarters2265 Upper Middle Road East, Oakville, ON, Canada, L6H 0G5, USA
  • Websitehttps://www.cardiolrx.com

Leadership

  • Mr. David G. Elsley MBAPresident, CEO & Director
  • Mr. Christopher J. Waddick C.A., C.M.A., CPA, MBACFO, Corporate Secretary & Director
  • Mr. Bernard Lim B.Sc.Chief Operating Officer
  • Dr. Andrew Warwick Hamer M.D.Chief Medical Officer and Head of Research & Development · b. 1962
  • Trevor BurnsInvestor Relations
  • Mr. John A. Geddes BSCPT, MBAVice President of Corporate Development

Financials

Income Statement

Currency: CAD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-0078.76K62.27K0000
Growth (%)-----20.94%-100.00%---
Cost of Revenue53.34K91.49K116.11K180.17K174.26K162.23K187.38K--
Gross Profit-53.34K-91.49K-116.11K-180.17K-112.00K-162.23K-187.38K--
Gross Margin----228.76%-179.87%----
Operating Expense1.54M7.30M10.78M16.06M30.46M30.33M22.29M--
Operating Income-1.59M-7.39M-10.89M-16.24M-30.57M-30.49M-22.47M-40.28M-34.32M
Operating Margin----20620.30%-49092.44%----
EBITDA-1.50M-7.30M-10.44M-16.02M-24.84M-22.66M-21.04M-36.52M-33.72M
EBITDA Margin----20342.19%-39891.00%----
Net Income-1.66M-15.89M-10.55M-16.20M-25.01M-22.82M-21.22M-36.68M-33.82M
Net Income Margin----20570.94%-40170.87%----
R&D441.26K1.53M2.72M8.25M8.59M13.99M10.73M14.01M14.02M
R&D as % of Total Revenue---10479.60%13802.10%----
Interest Expense60.56K663.37K62100----
Interest Expense % of Total Revenue---0.00%0.00%----

Balance Sheet

Currency: CAD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets3.22M24.68M15.50M15.89M87.88M45.76M36.70M31.86M23.62M
Total Liabilities366.76K2.41M830.83K2.62M11.64M7.25M8.45M7.14M5.74M
Total Equity2.85M22.27M14.67M13.27M76.24M38.51M28.25M24.73M17.88M
Cash2.36M16.73M6.96M14.03M83.90M43.83M34.93M30.58M21.42M
Total Debt190.04K269.22K190.75K156.57K117.58K53.76K174.34K158.53K125.52K
Net Debt-2.17M-16.46M-6.77M-13.87M-83.78M-43.77M-34.76M-30.42M-21.29M

Cash Flow

Currency: CAD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.29M-10.89M-11.38M-9.13M-23.55M-27.22M-25.18M-25.06M-23.85M
Investing Cash Flow-29.17K-13.79K-424.31K-40.60K-12.92K-74.71K-64.31K-21.29K-24.48K
Financing Cash Flow3.68M25.28M2.03M16.30M93.44M-53.93K-55.38K18.84M15.54M
Capital Expenditure29.17K13.79K424.31K40.60K12.92K74.71K64.31K21.29K24.48K
Free Cash Flow-1.32M-10.91M-11.80M-9.17M-23.56M-27.30M-25.24M-25.08M-23.88M
FCF to OCF102.26%100.13%103.73%100.44%100.05%100.27%100.26%100.08%100.10%

Earnings

Report DateJun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 28, 2019May 8, 2019Aug 13, 2019Nov 11, 2019Mar 26, 2020May 13, 2020Aug 13, 2020Nov 12, 2020Mar 31, 2021May 16, 2021Aug 16, 2021Nov 16, 2021Mar 22, 2022May 16, 2022Aug 10, 2022Nov 10, 2022Mar 30, 2023May 15, 2023Aug 10, 2023Nov 14, 2023Mar 28, 2024May 14, 2024Aug 12, 2024Nov 14, 2024Mar 31, 2025May 14, 2025Aug 14, 2025Nov 13, 2025Mar 31, 2026Apr 1, 2026Aug 12, 2026Nov 12, 2026
EPS Estimate0.000.000.000.000.000.000.000.00-0.090.000.00-0.13-0.160.00-0.09-0.12-0.14-0.14-0.18-0.14-0.17-0.15-0.14-0.15-0.15-0.12-0.12-0.09-0.10-0.13-0.11-0.12-0.13-0.12-0.10-0.11-0.08-0.09-0.05
EPS Actual-0.03-0.03-0.03-0.03-0.07-0.25-0.41-0.10-0.13-0.10-0.09-0.12-0.11-0.10-0.13-0.15-0.26-0.15-0.18-0.11-0.14-0.10-0.13-0.12-0.11-0.12-0.09-0.09-0.14-0.10-0.18-0.09-0.10-0.10-0.12-0.07-0.05-0.04-
Surprise---------44.44%--7.69%31.25%--44.44%-25.00%-85.71%-7.14%-0.22%21.43%17.65%33.33%7.14%20.00%26.67%0.00%25.00%0.00%-40.00%23.08%-63.64%22.88%23.08%16.67%-20.00%36.36%37.53%55.56%-
Timing-------After-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-market-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours--After-hours

Key Statistics & Ratios

Market Cap210.22M
Enterprise Value196.62M
Trailing P/E0.00
Forward P/E0.00
Price / Sales1014.87
Price / Book12.49
EPS-0.24
Book Value0.1479
Revenue (TTM)0
Gross Profit (TTM)78.76K
EBITDA-35.85M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-190.18%
Return on Assets-90.92%
Shares Outstanding121.51M
Shares Float91.98M
Beta0.61
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 5 analystsTarget 8.42
  • Strong Buy
    1
  • Buy
    4

Ownership Breakdown

Institutions
26.94%
Insiders
2.36%
Retail / Other
70.70%

Top Institutional Holders

  • Mmcap International Inc. Spc
    15.35M13.14%
  • Tejara Capital Ltd
    5.11M4.38%
  • Ikarian Capital, LLC
    2.73M2.33%
  • Citadel Advisors Llc
    796.53K0.68%
  • BOOTHBAY FUND MANAGEMENT, LLC
    794.88K0.68%
  • Two Sigma Investments LLC
    746.94K0.64%
  • INTEGRITY ALLIANCE, LLC.
    388.49K0.33%
  • The Goldman Sachs Group Inc
    332.40K0.28%
  • Morgan Stanley - Brokerage Accounts
    250.42K0.21%
  • Renaissance Technologies Corp
    229.81K0.20%
  • Jane Street Group LLC
    126.96K0.11%
  • We Are One Seven, LLC
    100.00K0.09%
  • Knoll Capital Management LP
    100.00K0.09%
  • 1832 Asset Management L.P
    100.00K0.09%
  • Summit Financial LLC
    99.11K0.08%
  • Susquehanna International Group, LLP
    70.40K0.06%
  • Geode Capital Management, LLC
    52.44K0.04%
  • JPMorgan Chase & Co
    48.08K0.04%
  • Marble Harbor Investment Counsel, LLC
    39.90K0.03%

Top Fund Holders

  • Fidelity Nasdaq Composite Index
    60.66K0.05%